Cannabis Pain Research May Be Measuring the Wrong Things, Experts Argue
A perspective piece argues clinical trials miss cannabis's true pain benefits by focusing on pain severity rather than outcomes patients value, like psychological coping, sleep, and opioid substitution.
Quick Facts
What This Study Found
While clinical trials show inconsistent evidence for cannabis reducing pain severity, qualitative research reveals patients value cannabis because it changes their psychological response to pain and improves sleep, social functioning, and ability to reduce opioid use. The authors argue these outcomes should be primary endpoints in future trials.
Key Numbers
Perspective references existing RCTs and qualitative studies without novel data. Identifies sleep quality, role/social functioning, opioid substitution, and psychological coping as understudied outcomes.
How They Did This
Expert perspective piece reviewing the disconnect between RCT findings on cannabis for chronic pain and patient-reported experiences from qualitative research.
Why This Research Matters
If clinical trials keep measuring the wrong outcomes, they will continue to produce ambiguous results that do not reflect real-world patient benefits, leading to policy confusion.
The Bigger Picture
The gap between what trials measure and what patients experience is a fundamental problem in cannabis-pain research. Patient-centered outcome measures could transform the evidence base and clarify cannabis's actual therapeutic role.
What This Study Doesn't Tell Us
Perspective piece without new empirical data. The proposed outcomes are harder to standardize and measure than pain severity. Patient perceptions may not always align with objective health outcomes.
Questions This Raises
- ?Would patient-centered outcomes change the evidence picture for cannabis and pain?
- ?How should opioid substitution be measured in trials?
- ?Can qualitative findings be translated into validated outcome measures?
Trust & Context
- Key Stat:
- Cannabis pain trials may miss real benefits by focusing on pain severity alone
- Evidence Grade:
- Expert perspective piece from established researchers, but presents argument rather than new evidence.
- Study Age:
- 2025 perspective piece calling for paradigm shift in cannabis-pain research.
- Original Title:
- Looking beyond traditional pain outcomes to better evaluate cannabis's true potential and limitations in chronic pain management.
- Published In:
- Experimental and clinical psychopharmacology, 33(5), 425-429 (2025)
- Authors:
- Mun, Chung Jung(7), Thrul, Johannes(11), Epstein, David H(2)
- Database ID:
- RTHC-07207
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does cannabis actually help with chronic pain?
Clinical trials show mixed results for pain reduction, but patients consistently report benefits. This perspective argues the trials are measuring the wrong things. Many patients value cannabis for its effects on coping, sleep, and opioid reduction rather than direct pain relief.
What should cannabis pain research measure?
The authors call for trials to focus on outcomes patients care about: psychological response to pain, sleep quality, social functioning, and ability to reduce opioid medications. Traditional pain severity may not capture cannabis's true therapeutic value.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBD-oil-quality-guide
- CBT-cannabis-recovery
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cannabis-relapse-cycle-pattern
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- medical-benefits-of-cannabis
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-before-surgery
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- seniors-older-adults-cannabis-risks-medications
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-breastfeeding-THC-breast-milk
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-07207APA
Mun, Chung Jung; Thrul, Johannes; Epstein, David H. (2025). Looking beyond traditional pain outcomes to better evaluate cannabis's true potential and limitations in chronic pain management.. Experimental and clinical psychopharmacology, 33(5), 425-429. https://doi.org/10.1037/pha0000795
MLA
Mun, Chung Jung, et al. "Looking beyond traditional pain outcomes to better evaluate cannabis's true potential and limitations in chronic pain management.." Experimental and clinical psychopharmacology, 2025. https://doi.org/10.1037/pha0000795
RethinkTHC
RethinkTHC Research Database. "Looking beyond traditional pain outcomes to better evaluate ..." RTHC-07207. Retrieved from https://rethinkthc.com/research/mun-2025-looking-beyond-traditional-pain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.